<!— STUB: needs expansion —>
Overview
Gestational diabetes mellitus (GDM) is a condition of glucose intolerance first recognized during pregnancy, affecting approximately 14% of pregnancies worldwide. It carries risks for both mother and offspring, including increased likelihood of developing type 2 diabetes postpartum.
Microbiome Associations
Emerging research indicates significant gut microbiome alterations in GDM, including both bacterial and fungal dysbiosis (fungal dysbiosis 2023 gdm pregnancy microbiome, wang 2026 intestinal fungal dysbiosis gdm adverse pregnancy outcomes). Microbiome-derived metabolites may contribute to insulin resistance mechanisms (susarla 2024 microbiome derived metabolites gestational diabetes risk).
Metal Associations
<!— NEEDS VERIFICATION — metal data sparse for GDM specifically; may overlap with type-2-diabetes signature —>
Associated Conditions
GDM shares microbial and metabolic patterns with type 2 diabetes, pcos, and obesity. Women with GDM have significantly elevated risk of developing type 2 diabetes later in life.
Key Studies
- fungal dysbiosis 2023 gdm pregnancy microbiome — Fungal dysbiosis in pregnancy
- vavreckova 2022 gut bacterial fungal microbiota pregnancy gdm — Bacterial and fungal microbiota in GDM
- wei 2022 16s rrna gut microbiota gestational diabetes — 16S rRNA gut microbiota analysis
Open Questions
- What specific metal dysregulation patterns characterize GDM distinct from T2D?
- Does gestational fungal dysbiosis persist postpartum and influence T2D conversion?
- Can microbiome-targeted interventions during pregnancy prevent GDM onset?